Iron Toxicity Guidelines

At-Risk Populations

Children aged 9-18 months are at highest risk for accidental iron poisoning due to ingestion of maternal iron tablets, particularly from pregnant mothers 1
Preterm and low-birthweight infants are also at greater risk, though typically from deficiency rather than toxicity 1

Hemodialysis patients receiving erythropoiesis-stimulating agents (ESAs) with intravenous iron are at substantial risk for iatrogenic iron overload 2, 3, 4
High-dose IV iron (>200 mg/month or cumulative doses >840 mg/6 months) significantly increases mortality and cardiovascular events 2
Patients receiving cumulative doses of 1640-2400 mg/6 months had hazard ratios of 3.7 for mortality and 5.1 for cardiovascular events compared to those receiving minimal or no IV iron 2
Ferritin levels consistently above 100 µg/L in dialysis patients are associated with increased risk of acute cardiocerebrovascular disease (HR: 2.22), infections (HR: 1.76), and death (HR: 2.28) 2
Patients with functional iron deficiency may be more prone to iatrogenic overload than those with true iron deficiency 2
Diabetic dialysis patients face higher risk of complications from iron overload affecting glucose regulation 4
Young dialysis patients with repeated graft failures and long cumulative dialysis vintage face prolonged exposure risk 4
Patients with viral hepatitis B or C, non-alcoholic steatohepatitis, or other liver diseases may experience aggravation from iron accumulation 2

Patients with genetic hemochromatosis (HFE-related, particularly C282Y homozygosity) develop progressive iron accumulation 5
Cardiac dysrhythmias and cardiomyopathy are the most common causes of sudden death in these patients 5
HH patients with cirrhosis face 30% mortality from hepatocellular carcinoma 5
Iron-loading anemias including thalassemia major, sideroblastic anemia, and chronic hemolytic anemias 5
Patients with chronic liver diseases (hepatitis C and B, alcohol-induced liver disease, porphyria cutanea tarda, fatty liver disease) 5
Ferroportin disease (SLC40A1 mutations) causes hereditary hemochromatosis type 4 with heterogeneous phenotypes 6
Patients with TMPRSS6 mutations causing iron-refractory iron deficiency anemia (IRIDA) paradoxically risk iron overload when attempting to correct anemia with IV iron 6

In dialysis patients, serum ferritin should not exceed 500 mg/L to avoid long-term iron toxicity risk, especially in children and adolescents 6
Historical data showed liver cell damage in dialysis patients with ferritin levels exceeding 7,500 ng/mL and transferrin saturation >88% 7, 8
MRI with quantitative assessment is the gold standard for cardiac and hepatic iron load monitoring 1
Rapid iron mobilization during chelation therapy may increase risk of cardiac complications 5
Early treatment before development of cirrhosis and/or diabetes significantly reduces morbidity and mortality, while delayed diagnosis can lead to irreversible organ damage 1